Autologous Cell Therapies Market - Global Forecast 2026-2032

Autologous cell therapies offer tailored treatment approaches for complex clinical needs where traditional interventions are often insufficient. Senior decision-makers must navigate a rapidly developing landscape, where emerging science and evolving operations present both opportunities and challenges for growth in the autologous cell therapies market.

Market Snapshot – Autologous Cell Therapies Market

The autologous cell therapies market is entering a phase of robust expansion, with a recorded increase in market value from USD 4.95 billion in 2025 to USD 5.27 billion in 2026. The sector’s compound annual growth rate (CAGR) stands at 6.88%, setting the stage for projected revenue of USD 7.89 billion by 2032. This progression reflects surging adoption in clinical settings, ongoing process enhancements, and rising investment across North America, EMEA, and Asia-Pacific. The market’s momentum is driven by growing physician confidence in these therapies and extensive regional activity supporting scale-up and accessibility.

Scope & Segmentation of the Autologous Cell Therapies Market

Therapy Areas: Dermatology, immunology, neurology, oncology, and orthopedics represent key therapeutic segments where autologous cell therapies target specific clinical challenges, such as healing, immune modulation, and tissue regeneration.
Cell Types: Modalities include dendritic cell technology, natural killer (NK) cell platforms—incorporating CAR NK strategies—as well as hematopoietic, induced pluripotent, mesenchymal stem cells, and T cell therapies like CAR T and TCR T approaches.
Source Tissues: Cell harvesting is performed from patient adipose tissue, bone marrow, cord blood, and peripheral blood, determining subsequent logistics, adaptation of therapies, and clinical outcomes.
Process Technologies: Key process technologies span cell expansion systems, formulation advancements (such as lyophilization and cryopreservation), genetic modification via both viral and non-viral approaches, and advanced isolation methods for purity and reproducibility.
End Users: Stakeholders include contract manufacturing organizations (CDMOs), hospitals in both academic and community settings, dedicated research institutes, and specialty clinics—all contributing to market adoption pathways and influencing workflow design.
Regions: The analysis encompasses the Americas, Europe, Middle East & Africa, and Asia-Pacific, each characterized by unique regulatory frameworks, infrastructure capacity, and reimbursement approaches influencing therapy access and execution.

Key Takeaways for Decision-Makers

Autologous cell therapies are transitioning from exploratory research to routinely adopted clinical products, supported by advances in manufacturing and bioengineering.
Process standardization and automated manufacturing systems are driving improvements in volume scalability, operational reproducibility, and reduction in patient-specific variability, enabling broader clinical use.
Industry leaders are leveraging strategic alliances, with cross-sector collaborations between biopharma, platform developers, and CDMOs enhancing the pace of clinical translation and optimizing delivery costs.
Increasing process complexity demands dedicated investment in digital analytics, resilient supply chains, and rigorous data management solutions to meet regulatory reporting and clinical transparency expectations.
Regional regulatory differences significantly shape market access strategies, requiring tailored approaches to manufacturing, reimbursement, and stakeholder engagement for sustained growth.
Operational priorities now focus on integrating payer requirements, generating clinical and health-economic evidence, and aligning with healthcare provider systems to support evolving value-based care standards.

Tariff Impact on Supply Chain and Manufacturing Choices

Tariff adjustments in the United States in 2025 altered the cost and availability of vital equipment and inputs for autologous cell therapy manufacturing. Organizations shifted procurement strategies by favoring domestic and tariff-exempt suppliers, increasing local production capacity, and accelerating the transition to nearshoring. CDMOs diversified sourcing contracts, while sponsors adopted new risk management measures to sustain stable supply flows. While these adaptations improved resilience, they introduced interim costs and the need for careful recalibration of portfolio strategies.

Methodology & Data Sources

The report applies a mixed-methods approach, synthesizing insights from structured interviews, comprehensive secondary literature reviews of regulatory and technical materials, and expert consultation sessions. This process ensures practical, validated findings tailored for the needs of manufacturers, clinical leaders, and investors in the autologous cell therapies market.

Why This Report Matters for the Autologous Cell Therapies Market

Empowers leaders to pinpoint vital levers, such as manufacturing process optimization, supply chain best practices, and payer alignment, for accelerating adoption while limiting operational risk.
Delivers detailed segmentation and multi-region perspectives, supporting informed investment decisions, development planning, and evaluation of strategic partnerships.
Offers tightly focused, evidence-driven guidance for portfolio strategy, commercial preparation, and negotiation with partners in advancing cellular therapy products.

Conclusion

Achieving sustainable growth in autologous cell therapies hinges on targeted investments in technology, resilient supply networks, and proactive engagement with payers. Market leaders integrating these initiatives are positioned for meaningful clinical and commercial benefits.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Autologous Cell Therapies Market, by Therapy Area

8.1. Dermatology
8.2. Immunology
8.2.1. Autoimmune Diseases
8.2.2. Transplant Rejection
8.3. Neurology
8.3.1. Parkinsons Disease
8.3.2. Spinal Cord Injury
8.4. Oncology
8.4.1. Hematological Cancer
8.4.2. Solid Tumors
8.5. Orthopedics
8.5.1. Bone Regeneration
8.5.2. Cartilage Repair

9. Autologous Cell Therapies Market, by Cell Type

9.1. Dendritic Cells
9.2. Nk Cells
9.3. Stem Cells
9.3.1. Hematopoietic Stem
9.3.2. Ipsc
9.3.3. Mesenchymal Stem
9.4. T Cells
9.4.1. Car T
9.4.2. Tcr T

10. Autologous Cell Therapies Market, by Source Tissue

10.1. Adipose Tissue
10.2. Bone Marrow
10.3. Cord Blood
10.4. Peripheral Blood

11. Autologous Cell Therapies Market, by Process Technology

11.1. Expansion
11.2. Formulation
11.2.1. Cryopreservation
11.2.2. Lyophilization
11.3. Genetic Modification
11.3.1. Non-Viral
11.3.2. Viral Vector
11.4. Isolation

12. Autologous Cell Therapies Market, by End User

12.1. Contract Manufacturing Org
12.2. Hospitals
12.2.1. Academic Medical Center
12.2.2. Community Hospital
12.3. Research Institutes
12.4. Specialty Clinics

13. Autologous Cell Therapies Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Autologous Cell Therapies Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Autologous Cell Therapies Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Autologous Cell Therapies Market
17. China Autologous Cell Therapies Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abata Therapeutics
18.6. Achilles Therapeutics plc
18.7. Adaptimmune Therapeutics PLC
18.8. Adicet Bio Inc.
18.9. AIVITA Biomedical, Inc.
18.10. Aspen Neuroscienc Inc.
18.11. Bellicum Phamaceuticals, Inc.
18.12. BioLineRx Ltd.
18.13. BioSpace, Inc.
18.14. BrainStorm Cell Limited.
18.15. Bristol-Myers Squibb Company
18.16. Carisma Therapeutics Inc.
18.17. Catalent, Inc.
18.18. Cell Therapy Catapult Ltd.
18.19. Fate Therapeutics Inc.
18.20. GentiBio, Inc.
18.21. IASO BioTherapeutics
18.22. Kyverna Therapeutics, Inc.
18.23. NOVADIP Biosciences S.A.
18.24. Orchard Therapeutics Inc.
18.25. T-knife Therapeutics, Inc.
18.26. ThermoGenesis Holdings, Inc.
18.27. Triumvira Immunologics Inc.
18.28. Vita Therapeutics, Inc.

List of Figures

FIGURE 1. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DERMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DERMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY AUTOIMMUNE DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY AUTOIMMUNE DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY TRANSPLANT REJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY TRANSPLANT REJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY TRANSPLANT REJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PARKINSONS DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PARKINSONS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PARKINSONS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SPINAL CORD INJURY, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SPINAL CORD INJURY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SPINAL CORD INJURY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HEMATOLOGICAL CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HEMATOLOGICAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HEMATOLOGICAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOLID TUMORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOLID TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY BONE REGENERATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY BONE REGENERATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY BONE REGENERATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CARTILAGE REPAIR, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CARTILAGE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CARTILAGE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DENDRITIC CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DENDRITIC CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DENDRITIC CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NK CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NK CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NK CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HEMATOPOIETIC STEM, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HEMATOPOIETIC STEM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HEMATOPOIETIC STEM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IPSC, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IPSC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IPSC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY MESENCHYMAL STEM, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY MESENCHYMAL STEM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY MESENCHYMAL STEM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CAR T, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CAR T, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CAR T, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY TCR T, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY TCR T, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY TCR T, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ADIPOSE TISSUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ADIPOSE TISSUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ADIPOSE TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY BONE MARROW, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY BONE MARROW, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CORD BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CORD BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CORD BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PERIPHERAL BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PERIPHERAL BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY EXPANSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY EXPANSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY EXPANSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CRYOPRESERVATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CRYOPRESERVATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY LYOPHILIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY LYOPHILIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY LYOPHILIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NON-VIRAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NON-VIRAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NON-VIRAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY VIRAL VECTOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY VIRAL VECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ISOLATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ISOLATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ISOLATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CONTRACT MANUFACTURING ORG, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CONTRACT MANUFACTURING ORG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CONTRACT MANUFACTURING ORG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ACADEMIC MEDICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ACADEMIC MEDICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ACADEMIC MEDICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COMMUNITY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COMMUNITY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COMMUNITY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 143. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 144. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 145. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2018-2032 (USD MILLION)
TABLE 146. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2018-2032 (USD MILLION)
TABLE 147. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 148. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 149. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2018-2032 (USD MILLION)
TABLE 150. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 151. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 155. NORTH AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2018-2032 (USD MILLION)
TABLE 161. NORTH AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2018-2032 (USD MILLION)
TABLE 162. NORTH AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 164. NORTH AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 169. LATIN AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 172. LATIN AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 174. LATIN AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 175. LATIN AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2018-2032 (USD MILLION)
TABLE 177. LATIN AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 178. LATIN AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. LATIN AMERICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2018-2032 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2018-2032 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2018-2032 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 197. EUROPE AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. EUROPE AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 199. EUROPE AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 200. EUROPE AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 201. EUROPE AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 202. EUROPE AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 203. EUROPE AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 204. EUROPE AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 205. EUROPE AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2018-2032 (USD MILLION)
TABLE 206. EUROPE AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2018-2032 (USD MILLION)
TABLE 207. EUROPE AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 208. EUROPE AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 209. EUROPE AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2018-2032 (USD MILLION)
TABLE 210. EUROPE AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 211. EUROPE AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 214. MIDDLE EAST AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 215. MIDDLE EAST AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 216. MIDDLE EAST AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 217. MIDDLE EAST AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 218. MIDDLE EAST AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 219. MIDDLE EAST AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 220. MIDDLE EAST AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2018-2032 (USD MILLION)
TABLE 221. MIDDLE EAST AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2018-2032 (USD MILLION)
TABLE 222. MIDDLE EAST AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 223. MIDDLE EAST AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 224. MIDDLE EAST AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2018-2032 (USD MILLION)
TABLE 225. MIDDLE EAST AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. MIDDLE EAST AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 227. AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 228. AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 229. AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 230. AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 231. AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 232. AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 233. AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 234. AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 235. AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2018-2032 (USD MILLION)
TABLE 236. AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2018-2032 (USD MILLION)
TABLE 237. AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 238. AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 239. AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2018-2032 (USD MILLION)
TABLE 240. AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 241. AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 242. ASIA-PACIFIC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 243. ASIA-PACIFIC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 244. ASIA-PACIFIC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 245. ASIA-PACIFIC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 246. ASIA-PACIFIC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 247. ASIA-PACIFIC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 248. ASIA-PACIFIC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 249. ASIA-PACIFIC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 250. ASIA-PACIFIC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2018-2032 (USD MILLION)
TABLE 251. ASIA-PACIFIC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2018-2032 (USD MILLION)
TABLE 252. ASIA-PACIFIC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 253. ASIA-PACIFIC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 254. ASIA-PACIFIC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2018-2032 (USD MILLION)
TABLE 255. ASIA-PACIFIC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 256. ASIA-PACIFIC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 257. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 258. ASEAN AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. ASEAN AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 260. ASEAN AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 261. ASEAN AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 262. ASEAN AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 263. ASEAN AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 264. ASEAN AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 265. ASEAN AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 266. ASEAN AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2018-2032 (USD MILLION)
TABLE 267. ASEAN AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2018-2032 (USD MILLION)
TABLE 268. ASEAN AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 269. ASEAN AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 270. ASEAN AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2018-2032 (USD MILLION)
TABLE 271. ASEAN AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 272. ASEAN AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 273. GCC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 274. GCC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 275. GCC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 276. GCC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 277. GCC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 278. GCC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 279. GCC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 280. GCC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 281. GCC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2018-2032 (USD MILLION)
TABLE 282. GCC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2018-2032 (USD MILLION)
TABLE 283. GCC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 284. GCC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 285. GCC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2018-2032 (USD MILLION)
TABLE 286. GCC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 287. GCC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 288. EUROPEAN UNION AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 289. EUROPEAN UNION AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 290. EUROPEAN UNION AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 291. EUROPEAN UNION AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 292. EUROPEAN UNION AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 293. EUROPEAN UNION AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 294. EUROPEAN UNION AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 295. EUROPEAN UNION AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 296. EUROPEAN UNION AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2018-2032 (USD MILLION)
TABLE 297. EUROPEAN UNION AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2018-2032 (USD MILLION)
TABLE 298. EUROPEAN UNION AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 299. EUROPEAN UNION AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 300. EUROPEAN UNION AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2018-2032 (USD MILLION)
TABLE 301. EUROPEAN UNION AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 302. EUROPEAN UNION AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 303. BRICS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 304. BRICS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 305. BRICS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 306. BRICS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 307. BRICS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 308. BRICS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 309. BRICS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 310. BRICS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 311. BRICS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2018-2032 (USD MILLION)
TABLE 312. BRICS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2018-2032 (USD MILLION)
TABLE 313. BRICS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 314. BRICS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 315. BRICS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFIC

Companies Mentioned

The key companies profiled in this Autologous Cell Therapies market report include:

Abata Therapeutics
Achilles Therapeutics plc
Adaptimmune Therapeutics PLC
Adicet Bio Inc.
AIVITA Biomedical, Inc.
Aspen Neuroscienc Inc.
Bellicum Phamaceuticals, Inc.
BioLineRx Ltd.
BioSpace, Inc.
BrainStorm Cell Limited.
Bristol-Myers Squibb Company
Carisma Therapeutics Inc.
Catalent, Inc.
Cell Therapy Catapult Ltd.
Fate Therapeutics Inc.
GentiBio, Inc.
IASO BioTherapeutics
Kyverna Therapeutics, Inc.
NOVADIP Biosciences S.A.
Orchard Therapeutics Inc.
T-knife Therapeutics, Inc.
ThermoGenesis Holdings, Inc.
Triumvira Immunologics Inc.
Vita Therapeutics, Inc.

Table Information

Report Attribute	Details
No. of Pages	185
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 5.27 Billion
Forecasted Market Value ( USD ) by 2032	$ 7.89 Billion
Compound Annual Growth Rate	6.8%
Regions Covered	Global
No. of Companies Mentioned	25

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3511EUR$3,939USD£3,045GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3787EUR$4,249USD£3,285GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5133EUR$5,759USD£4,452GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6212EUR$6,969USD£5,387GBP

Market Snapshot – Autologous Cell Therapies Market

Scope & Segmentation of the Autologous Cell Therapies Market

Key Takeaways for Decision-Makers

Tariff Impact on Supply Chain and Manufacturing Choices

Methodology & Data Sources

Why This Report Matters for the Autologous Cell Therapies Market

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Cell Therapy Biomanufacturing Market - Global Forecast 2026-2032

Cell Therapy - Global Strategic Business Report

Autologous Cell Therapy Market Report and Forecast 2025-2034

Gene-Circuit Cell Therapy Market Report 2025

Autologous Cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)